Elutia (ELUT) EBITDA Margin (2019 - 2026)
Elutia (ELUT) reported EBITDA Margin of 203.85% for Q1 2026, up 2580.0% on a YoY basis from 7.61% in Q1 2025, and down 1.63% sequentially from 200.58% in Q4 2025.
Elutia (ELUT) EBITDA Margin (2019 - 2026) Analysis & Trends
Elutia (ELUT) has 8 years of EBITDA Margin data on file, last reported at 203.85% in Q1 2026.
- For the quarter ending Q1 2026, EBITDA Margin rose 2580.0% year-over-year to 203.85%; the trailing twelve-month figure through Mar 2026 stood at 175.27% (up 2779.0% YoY), and the FY2025 full-year result was 218.91%, down 662.0% from the prior year.
- EBITDA Margin retreated to 203.85% in Q1 2026, from 200.58% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 60.22% in Q1 2022 to a low of 264.84% in Q4 2024.
- A 5-year average of 155.51% and a median of 144.82% in 2023 frame the typical range for EBITDA Margin.
- Across the five-year window, EBITDA Margin sank 13024 bps in 2024 and jumped 9382 bps in 2025, its largest moves.
- Tracing ELUT's EBITDA Margin over 5 years: stood at 144.63% in 2022, then dropped by 0 bps to 144.82% in 2023, then sank by 83 bps to 264.84% in 2024, then grew by 24 bps to 200.58% in 2025, then declined by 2 bps to 203.85% in 2026.
- Business Quant data shows ELUT's EBITDA Margin at 203.85% in Q1 2026, 200.58% in Q4 2025, and 156.73% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 19.10% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 28.97% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 21.42% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 6.17% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 10.04% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Elutia | 39.99 Mn | 11.50 Mn | 1.80 Mn | -203.85% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -203.85% |
| Dec 31, 2025 | -200.58% |
| Sep 30, 2025 | -156.73% |
| Jun 30, 2025 | -157.67% |
| Mar 31, 2025 | -229.65% |
| Dec 31, 2024 | -264.84% |
| Sep 30, 2024 | -250.55% |
| Jun 30, 2024 | -135.27% |
| Mar 31, 2024 | -126.67% |
| Dec 31, 2023 | -144.82% |
| Sep 30, 2023 | -120.30% |
| Jun 30, 2023 | -99.34% |
| Mar 31, 2023 | -130.46% |
| Dec 31, 2022 | -144.63% |
| Sep 30, 2022 | -153.31% |
| Jun 30, 2022 | -64.74% |
| Mar 31, 2022 | -60.22% |
| Dec 31, 2021 | -71.47% |
| Sep 30, 2021 | -60.74% |
| Jun 30, 2021 | -37.79% |